WPC
GSK icon

Wedmont Private Capital’s GSK GSK Stock Holding History

Wedmont Private Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Buy
4,325
+348
+9% +$17.8K ﹤0.01% 967
2026
Q2 		$210K Buy
3,977
+11
+0.3% +$582 0.01% 899
2026
Q1 		$228K Buy
+3,966
New +$215K 0.01% 768

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Wedmont Private Capital's GSK Position: Q3 2026 in Review

Wedmont Private Capital increased its GSK (GSK) stake by 8.8% in Q3 2026, buying an estimated $17.8K and bringing the position to 4,325 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Wedmont Private Capital first reported a position in GSK in Q1 2026 and has held it in 3 quarters since. The position peaked at $228K in Q1 2026. 35 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Wedmont Private Capital held 4,325 shares of GSK worth $201K as of Q3 2026.
  • Wedmont Private Capital bought 348 GSK shares in Q3 2026, an estimated $17.8K.
  • GSK made up ﹤0.01% of Wedmont Private Capital's portfolio in Q3 2026, its #967 holding.
  • Wedmont Private Capital first reported a position in GSK in Q1 2026 and has held it in 3 quarters since.
  • Wedmont Private Capital's GSK position peaked at $228K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.